\ lung disease Archives ~ ScienceBeta



Tag: lung disease

Inhalable Form Of Messenger RNA Created

Messenger RNA, which can induce cells to produce therapeutic proteins, holds great promise for treating a variety of diseases. The biggest obstacle to this approach so far has been finding safe and efficient ways to deliver mRNA molecules to the target cells. In an advance that could lead to new treatments for lung disease, MIT […]

A Genetic Risk Factor For Young Age Onset Tuberculosis

Tuberculosis, caused by Mycobacterium tuberculosis, was in 2016 the most common causative pathogen for death by infectious diseases. Investigating the biology of infection and disease development is important in the quest to end tuberculosis. In a new study, researchers conducted an integrative analysis of human and pathogen genome variations in tuberculosis. Genome-wide association study (GWAS) […]

Stem Cell Therapy For Lung Fibrosis Conditions

Promising research towards a possible stem cell treatment for several lung conditions has been developed by scientists from the UNC School of Medicine and North Carolina State University. The conditions include idiopathic pulmonary fibrosis (IPF), chronic obstructive pulmonary disease (COPD), and cystic fibrosis — often-fatal conditions that affect tens of millions of Americans. The team […]

Cystic Fibrosis Patients In Canada Outlive US Counterparts

Although people diagnosed with cystic fibrosis are surviving longer than ever before, their lifespan is nearly 10 years longer in Canada than the United States, reports new research. Cystic fibrosis is a genetic disease that affects the lungs, pancreas, liver, intestines, sinuses, and sex organs. Cystic fibrosis causes your mucus to be thick and sticky. […]

Phage Therapy Effective For Drug Resistant Lung Infection Treatment

Phage therapy may be a safe and effective antibiotic alternative for the treatment of cystic fibrosis lung infections, scientists from the University of Liverpool’s Institute of Infection and Global Health have shown. Chronic lung infections caused by the bacterium Pseudomonas aeruginosa are becoming increasingly difficult to treat due to antimicrobial resistance (AMR). With limited alternative […]